This is a record

Captured October 16, 2024 7:24 pm

View Mode: Standard Screenshot
View the live page
What is Perma.cc?
Title
Insilico’s AI drug enters Phase II IPF trial
Description
Insilico plans to investigate its AI-generated INS018_055 in patients with IPF based in the US and China.
Flag as inappropriate